Donika Ivanova Selected Research

2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate

1/2022	Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes.
1/2018	Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib.
1/2017	Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes.
11/2016	Inhibition of the Pentose-phosphate Pathway Selectively Sensitizes Leukemia Lymphocytes to Chemotherapeutics by ROS-independent Mechanism.
4/2016	Docosahexaenoic Acid Sensitizes Leukemia Lymphocytes to Barasertib and Everolimus by ROS-dependent Mechanism Without Affecting the Level of ROS and Viability of Normal Lymphocytes.
12/2015	2-Deoxy-D-glucose Sensitizes Cancer Cells to Barasertib and Everolimus by ROS-independent Mechanism(s).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donika Ivanova Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 11/2013
6	Leukemia 01/2022 - 12/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 12/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2016
1	Body Weight (Weight, Body) 02/2022
1	Melanoma (Melanoma, Malignant) 01/2020
1	Atherosclerosis 10/2017
1	Inflammation (Inflammations) 10/2017
1	Carcinogenesis 11/2013

Drug/Important Bio-Agent (IBA)

7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 12/2015
6	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 01/2022 - 12/2015
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
5	Everolimus FDA Link 01/2018 - 12/2015
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2015
2	lonafarnib (SCH 66336)IBA 01/2022 - 04/2016
2	Succinic Acid (Succinate)IBA 01/2022 - 01/2020
2	Vitamin K 3 (Menadione)FDA Link 01/2020 - 01/2018
2	Superoxides (Superoxide)IBA 01/2020 - 12/2015
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2018 - 01/2018
2	Free RadicalsIBA 10/2017 - 11/2013
1	Benzoic Acid (Potassium Benzoate)FDA Link 02/2022
1	SilymarinIBA 02/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Drug CombinationsIBA 01/2020
1	LigandsIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Dicumarol (Dicoumarol)FDA Link 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	quinone (benzoquinone)IBA 01/2020
1	Cytostatic AgentsIBA 01/2020
1	CalciumIBA 01/2018
1	Vitamin K FDA Link 01/2018
1	VitaminsIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2017
1	MelatoninIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	6-Aminonicotinamide (6 Aminonicotinamide)IBA 11/2016
1	palbociclibIBA 04/2016
1	Docosahexaenoic AcidsIBA 04/2016
1	nitroxylIBA 12/2015
1	RotenoneIBA 12/2015
1	2-MethoxyestradiolIBA 12/2015
1	TEMPOIBA 12/2015
1	Deoxyglucose (2 Deoxy D glucose)IBA 12/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2013
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2018
1	Oral Administration 01/2020
1	Aftercare (After-Treatment) 04/2016